266 related articles for article (PubMed ID: 7109539)
1. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
2. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
Gonnerman WA; Kandel R; Cathcart ES
Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.
Kisilevsky R; Boudreau L
Lab Invest; 1983 Jan; 48(1):53-9. PubMed ID: 6823091
[TBL] [Abstract][Full Text] [Related]
6. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
7. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
[TBL] [Abstract][Full Text] [Related]
8. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
Sørby R; Espenes A; Landsverk T; Westermark G
Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
[TBL] [Abstract][Full Text] [Related]
10. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
[TBL] [Abstract][Full Text] [Related]
11. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
12. Amyloid resistance in A/J mice. Studies with a transfer model.
Wohlgethan JR; Cathcart ES
Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
[TBL] [Abstract][Full Text] [Related]
13. Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.
Abankwa GV; Ali-Khan Z
Br J Exp Pathol; 1988 Feb; 69(1):123-32. PubMed ID: 3348956
[TBL] [Abstract][Full Text] [Related]
14. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
Kisilevsky R; Tan R; Subrahmanyan L; Snow A
Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
[TBL] [Abstract][Full Text] [Related]
15. Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.
Abankwa GV; Ali-Khan Z
Br J Exp Pathol; 1988 Feb; 69(1):133-48. PubMed ID: 3162377
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
Kisilevsky R; Boudreau L; Foster D
Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster.
Hol PR; Snel FW; Niewold TA; Gruys E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):273-81. PubMed ID: 2879382
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
20. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
Kawahara E; Shiroo M; Nakanishi I; Migita S
Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
